Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites

United European Gastroenterol J. 2019 Jun;7(5):651-661. doi: 10.1177/2050640619843000. Epub 2019 Apr 5.

Abstract

Background: Spontaneous bacterial peritonitis (SBP) is defined as an ascitic polymorphonuclear cell count (A-PMN) > 250 cells/µl.

Objective: We aimed to investigate the prognostic value of ascitic fluid cell counts in patients without SBP.

Patients and methods: A total of 178 patients were included and stratified by ascitic cell counts at index paracentesis: A-LEUK-low (<250/µl), A-LEUK-intermediate (250-500/µl) and A-LEUK-SBP (>500/µl) for leukocytes; A-PMN-low (<125/µl), A-PMN-intermediate (125-250/µl) and A-PMN-SBP (>250/µl) for PMN cells.

Results: One-year mortality was comparable between group A-LEUK-SBP (53.9%) and patients with subclinical cell counts (34.5% for A-LEUK-low, 43.5% for A-LEUK-intermediate, log-rank p = 0.547). However, we observed an increase in one-year mortality already in group A-PMN-intermediate with 75% and A-PMN-SBP with 80.9% (vs 40.5% for A-PMN-low, log-rank p = 0.016).Importantly, increases of A-PMN cell counts between two paracenteses were associated with increased mortality: per 100 cells/µl increase of absolute A-PMN cell count: hazard ratio (HR): 1.03 (95% confidence interval (CI): 1.01-1.06), p = 0.005; per 5% increase of relative PMN cell count: HR: 1.15 (95% CI: 1.06-1.26), p = 0.001.

Conclusion: Patients with PMN cell counts of 125-250/µl are at high risk for mortality, which was very similar to SBP patients with PMN cell counts >250/µl. This highlights the need for preventive strategies. The prognostic value of changes in relative ascitic PMN cell counts should be evaluated in future studies.

Keywords: Ascites; cirrhosis; mortality; polymorphonuclear cells; spontaneous bacterial peritonitis.

MeSH terms

  • Ascites / complications*
  • Ascites / pathology*
  • Ascitic Fluid / pathology*
  • Female
  • Humans
  • Leukocyte Count*
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / mortality
  • Liver Cirrhosis / pathology*
  • Male
  • Middle Aged
  • Neutrophils*
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis